PDCD1 and cancer: Since PD-L1/PD-1 is a common pathway that functions in a wide spectrum of cancers, we performed a meta-analysis by incorporating all the available evidence to evaluate the association between clincopathological features and PD-L1 expression, aiming to identify those with high PD-L1 expression that may benefit from anti-PD-L1 therapy.